Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal rod cell | 6 studies | 40% ± 23% | |
| retinal cone cell | 5 studies | 60% ± 30% | |
| retinal ganglion cell | 3 studies | 62% ± 21% | |
| neuron | 3 studies | 68% ± 3% | |
| glutamatergic neuron | 3 studies | 26% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 3 studies | 41% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 96% | 2481.17 | 2531 / 2642 | 97% | 19.60 | 687 / 705 |
| adrenal gland | 10% | 47.22 | 25 / 258 | 72% | 12.60 | 165 / 230 |
| muscle | 44% | 311.45 | 354 / 803 | 0% | 0 | 0 / 0 |
| breast | 1% | 2.38 | 4 / 459 | 38% | 1.39 | 429 / 1118 |
| uterus | 0% | 0 | 0 / 170 | 12% | 0.33 | 56 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 0.31 | 5 / 45 |
| pancreas | 0% | 0 | 0 / 328 | 10% | 0.78 | 17 / 178 |
| ovary | 0% | 0 | 0 / 180 | 9% | 0.19 | 38 / 430 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.98 | 5 / 80 |
| thymus | 0% | 1.36 | 3 / 653 | 6% | 0.09 | 35 / 605 |
| prostate | 1% | 4.31 | 2 / 245 | 4% | 0.18 | 21 / 502 |
| skin | 0% | 0.64 | 4 / 1809 | 4% | 0.13 | 19 / 472 |
| bladder | 0% | 0 | 0 / 21 | 4% | 0.27 | 20 / 504 |
| lung | 0% | 0 | 0 / 578 | 3% | 0.09 | 40 / 1155 |
| kidney | 0% | 0 | 0 / 89 | 3% | 0.31 | 31 / 901 |
| esophagus | 0% | 0.70 | 1 / 1445 | 3% | 0.06 | 6 / 183 |
| stomach | 0% | 0 | 0 / 359 | 3% | 0.06 | 9 / 286 |
| intestine | 0% | 0.47 | 2 / 966 | 2% | 0.05 | 8 / 527 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.03 | 6 / 406 |
| peripheral blood | 0% | 0.47 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0055088 | Biological process | lipid homeostasis |
| GO_0045599 | Biological process | negative regulation of fat cell differentiation |
| GO_0046513 | Biological process | ceramide biosynthetic process |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0050291 | Molecular function | sphingosine N-acyltransferase activity |
| Gene name | TLCD3B |
| Protein name | Epididymis secretory sperm binding protein (Family with sequence similarity 57, member B, isoform CRA_b) Ceramide synthase (EC 2.3.1.-) (Protein FAM57B) (TLC domain-containing protein 3B) TLC domain containing 3B |
| Synonyms | hCG_1770714 FAM57B FP1188 |
| Description | FUNCTION: Involved in ceramide synthesis. . |
| Accessions | ENST00000279389.8 [Q71RH2-2] ENST00000561666.5 ENST00000569508.6 ENST00000564806.1 H3BST4 Q71RH2 H3BUS2 I3L180 ENST00000571269.1 ENST00000380495.9 [Q71RH2-1] H3BUM7 F1T0F5 |